The board of directors of Beijing Tong Ren Tang Chinese Medicine Company Limited announced that with effect from 31 August 2023, Ms. Ding Yong Ling (?Ms. Ding?) has retired as the executive director of the Company, the chairman of the Board and authorised representative of the Company due to Ms. Ding has reached the retirement age. Ms. Ding has confirmed that she has no disagreement with the Board or the Company and there is no matter in relation to her retirement that needs to be brought to the attention of shareholders of the Company or The Stock Exchange of Hong Kong Limited (the ?Stock Exchange?). Following the retirement of Ms. Ding, the Company does not have a chairman of the Board and deviates from paragraph C.2 of the Corporate Governance Code set out in Appendix 14 of the Rules Governing the Listing of Securities on the Stock Exchange (?Listing Rules?).

The Company will identify a suitable candidate to fill the vacancy of the chairman of the Board as soon as practicable and will make further announcement as and when appropriate.